[Difluocortolone valerate for topical use in dermatology].
59 patients with various skin disorders - most of them in the acute stage - were treated in this trial. The topical investigational preparation was a cream containing 0.1% diflucortolone valerate. The results confirmed that the preparation has a quick-acting and effective antipruritic and antiphlogistic action. The results achieved were good or very good in 91.52% of cases and moderate in 8.47%. No side effects were observed.
D000287:Administration, Topical; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005448:Fluocortolone / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D009824:Ointments; D011244:Pregnadienediols / Q000627:therapeutic use*; D012871:Skin Diseases / Q000188:drug therapy*; D014631:Valerates / Q000627:therapeutic use
D009824:Ointments; D011244:Pregnadienediols; D014631:Valerates; D005448:Fluocortolone
Diflucortolonvalerianat zur topischen Anwendung in der Dermatologie